Skip to main content
STI 2024 Prevention Conference Main banner
Final Program


Abstract Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  1. Home

  • Tuesday, Sep 17th
    1:30 PM - 2:30 PM EST
    Debate 1: Antimicrobial Resistance Issues Should Prevent Use of Doxy PEP; Debate 2: Direct-to-Consumer STI Testing Will Increase Sexual Health Equity
    Location: Grand Ballroom
    Moderator: Jami Leichliter, PhD (she/her/hers) – Centers for Disease Control and Prevention
    Moderator: Keosha T. Bond, EdD, MPH, CHES (she/her/hers) – CUNY School of Medicine
    CE Available: CE Code C
  • Tuesday, Sep 17th
    1:30 PM - 2:30 PM EST
    D1.1 - Antimicrobial Resistance Issues Should Prevent Use of Doxy PEP: Pro
    Location: Grand Ballroom
    Presenter: Colleen Kelley, MD, MPH – Emory University School of Medicine
    CE Available: CE Code C
  • Tuesday, Sep 17th
    1:30 PM - 2:30 PM EST
    D1.2 - Antimicrobial Resistance Issues Should Prevent Use of Doxy PEP: Con
    Location: Grand Ballroom
    Presenter: Jonathan Mermin, MD, MPH (he/him/his) – Centers for Disease Control and Prevention
    CE Available: CE Code C
  • Tuesday, Sep 17th
    1:30 PM - 2:30 PM EST
    D2.1 - Direct-to-Consumer STI Testing Will Increase Sexual Health Equity: Pro
    Location: Grand Ballroom
    Presenter: Yukari C. Manabe, MD (she/her/hers) – Johns Hopkins School of Medicine
    CE Available: CE Code C
  • Tuesday, Sep 17th
    1:30 PM - 2:30 PM EST
    D2.2 - Direct-to-Consumer STI Testing Will Increase Sexual Health Equity: Con
    Location: Grand Ballroom
    Presenter: Khalil G. Ghanem, MD, PhD – Johns Hopkins University School of Medicine
    CE Available: CE Code C